← Open Payments lookup

CHELSIE MONROE: Open Payments

NPI 1104235761 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$417,359 in 651 payments from 18 companies in 2025. Trend: 2023 $240,634 · 2024 $254,391 · 2025 $417,359

Speaker / faculty: $232,136Consulting: $66,977Honoraria: $60,151Travel & lodging: $44,928Food & beverage: $13,075Education: $91
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.139$105,417
Teva Pharmaceuticals USA, Inc.80$79,038
Axsome Therapeutics, Inc.124$72,878
ABBVIE INC.75$49,255
Alkermes, Inc.86$43,249
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)51$26,580
E.R. Squibb & Sons, L.L.C.51$25,156
Otsuka America Pharmaceutical, Inc.24$14,822
Otsuka Pharmaceutical Development & Commercialization, Inc.4$298
Janssen Scientific Affairs, LLC2$190

Products named: INGREZZA, Auvelity, AUSTEDO XR, VRAYLAR, LYBALVI, UZEDY, CAPLYTA, COBENFY.

Industry payments across CO — which companies pay providers there.